Nasdaq: $25.89 (-0.35) | AIM: £3.77 (+0.07)
News & Presentations
Previous Article   |   Next Article
Oncology / Immunology, RNS Announcements | 28 Nov 2012

Chi-Med and Nestlé Health Science establish Joint Venture